Christopher J. Gostout serves as Executive at Apollo Endosurgery, Inc., where they oversee executive responsibilities. Since joining the company, Christopher J. Gostout has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 4, 2023 involved selling 90,267 shares valued at $0.
Christopher J. Gostout currently holds 90,267 shares of Apollo Endosurgery, Inc. (APEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher J. Gostout has been a net neutral trader of APEN stock. They have purchased $0 and sold $0 worth of shares.
Christopher J. Gostout's most recent insider trade was on Apr 4, 2023, when they sold 90,267 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 10, 2021 | APEN | $0 | Award | 10,020 | $N/A | Discretionary |
| May 7, 2020 | APEN | $0 | Award | 34,561 | $N/A | Discretionary |
| May 7, 2019 | APEN | $0 | Award | 16,335 | $N/A | Discretionary |
| Feb 28, 2018 | APEN | $0 | Award | 2,537 | $N/A | Discretionary |